Exact Mass: 191.046151
Exact Mass Matches: 191.046151
Found 191 metabolites which its exact mass value is equals to given mass value 191.046151,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Nitrilotriacetic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents
Isosorbide Mononitrate
Isosorbide mononitrate (ISMN), sold under the names Imdur and Monoket, among others, is an organic nitrate used principally in the prophylactic treatment of angina pectoris (ischemic chest pain). ISMN is an active metabolite of isosorbide dinitrate and exerts qualitatively similar effects. Like other organic nitrates, ISMN acts as a prodrug for its active metabolite, nitric oxide, which mediates the therapeutic action of ISMN. Nitric oxide works on both arteries and veins, but predominantly veins. Nitric oxide functions by relaxing veins and reducing the central venous pressure, thereby causing venous pooling and a decrease in the venous return to the heart, thus decreasing cardiac preload (PMID: 31643263). The net effect when administering ISMN is therefore a reduced workload for the heart and an improvement in the oxygen supply/demand balance of the myocardium. ISMN is not subject to first pass metabolism in the human liver. Detectable metabolites include isosorbide, sorbitol, and 2-glucuronide of mononitrate, which are pharmacologically inactive (PMID: 1449102). Research on ISMN as a cervical ripener to reduce time at hospital to birth is supportive (PMID: 23983763). Isosorbide mononitrate is only found in individuals who have consumed or used this drug. C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
gamma-Carboxyglutamic acid
Carboxyglutamic acid (or the conjugate base, carboxyglutamate), is an uncommon amino acid introduced into proteins by a post-translational carboxylation of glutamic acid residues. This modification is found, for example, in clotting factors and other proteins of the coagulation cascade. This modification introduces an affinity for calcium ions. In the blood coagulation cascade, Vitamin K is required to introduce gamma-carboxylation of clotting factors II, VII, IX, X and protein Z.
(2s,3r,4s,5r)-3,4,5-Trihydroxy-6-oxopiperidine-2-carboxylic acid
O-Oxalylhomoserine
O-oxalylhomoserine is a member of the class of compounds known as alpha amino acids. Alpha amino acids are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). O-oxalylhomoserine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). O-oxalylhomoserine can be found in grass pea, which makes O-oxalylhomoserine a potential biomarker for the consumption of this food product.
L-quinate
L-quinate, also known as L-quinic acid, belongs to quinic acids and derivatives class of compounds. Those are compounds containing a quinic acid moiety (or a derivative thereof), which is a cyclitol made up of a cyclohexane ring that bears four hydroxyl groups at positions 1,3.4, and 5, as well as a carboxylic acid at position 1. L-quinate is very soluble (in water) and a weakly acidic compound (based on its pKa). L-quinate can be found in a number of food items such as fireweed, yellow wax bean, japanese walnut, and black cabbage, which makes L-quinate a potential biomarker for the consumption of these food products. Quinic acid is a cyclitol, a cyclic polyol, and a cyclohexanecarboxylic acid. It is a crystalline acid obtained from cinchona bark, coffee beans, and other plant products and made synthetically by hydrolysis of chlorogenic acid. Quinic acid is also implicated in the perceived acidity of coffee. It is a constituent of the tara tannins .
(Z)-2-(4-methoxyphenyl)ethenyl isothiocyanate|(Z)-coriandrin
6-(2-methylsulfanyl-ethyl)-[1,3]oxazinane-2-thione
4-ETHOXY-2-FLUOROANILINE HYDROCHLORIDE
C8H11ClFNO (191.05131579999997)
2,4-Triazole-3-thione,2,4-dihydro-5-methyl-4-phenyl-3H-1
Potassium trifluoro[(pyrrolidin-1-yl)methyl]borate
5-(Trifluoromethyl)pyridine-2-boronic acid
C6H5BF3NO2 (191.03654160000002)
4-(Trifluoromethyl)pyridine-2-boronic acid
C6H5BF3NO2 (191.03654160000002)
2-(Trifluoromethyl)pyridine-4-boronic acid
C6H5BF3NO2 (191.03654160000002)
2-(Trifluoromethyl)pyridine-3-boronic acid
C6H5BF3NO2 (191.03654160000002)
6-(Trifluoromethyl)pyridine-2-boronic acid
C6H5BF3NO2 (191.03654160000002)
N-Methyl 4-fluoro-2-methoxyaniline hydrochloride
C8H11ClFNO (191.05131579999997)
deuterio 2-[bis(1,1-dideuterio-2-deuteriooxy-2-oxoethyl)amino]-2,2-dideuterioacetate
2-(4-Fluorophenoxy)-1-ethanamine(HCl)
C8H11ClFNO (191.05131579999997)
2-ETHOXY-4-FLUOROANILINE HYDROCHLORIDE
C8H11ClFNO (191.05131579999997)
Methyl 1H-pyrrolo[2,3-b]pyridine-4-carboxylate 1-oxide
(S)-2-amino-2-(4-fluorophenyl)ethanol hydrochloride
C8H11ClFNO (191.05131579999997)
2-(3-Fluorophenoxy)-1-ethanamine(HCl)
C8H11ClFNO (191.05131579999997)
1,2-dihydroimidazo[2,1-b][1,3]benzothiazol-7-amine
4-(4-methyl-3H-1,3-thiazol-2-ylidene)cyclohexa-2,5-dien-1-one
(2-FLUORO-4-METHOXYPHENYL)METHANAMINE HYDROCHLORIDE
C8H11ClFNO (191.05131579999997)
5-(Trifluoromethyl)-3-pyridylboronic acid
C6H5BF3NO2 (191.03654160000002)
1-(2-aminoethyl)pyrimidine-2,4-dione,hydrochloride
2-Trifluoromethyl-5-pyridineboric acid
C6H5BF3NO2 (191.03654160000002)
Amiphenazole
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019141 - Respiratory System Agents
(6R-TRANS)-7-AMINO-8-OXO-3-(((1-(SULPHOMETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLICACID
2-AMINO-1-(4-FLUOROPHENYL)ETHANOL HYDROCHLORIDE
C8H11ClFNO (191.05131579999997)
2-AMINO-1-(3-FLUOROPHENYL)ETHANOL HYDROCHLORIDE
C8H11ClFNO (191.05131579999997)
(2S)-2-(carbamoylamino)-4-(methylsulfanyl)butanoate
(2R)-2-(carbamoylamino)-4-(methylsulfanyl)butanoate
Isosorbide Mononitrate
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
NITRILOTRIACETIC ACID
D064449 - Sequestering Agents > D002614 - Chelating Agents
gamma-carboxy-L-glutamic acid
A non-proteinogenic L-alpha-amino acid that is L-glutamic acid in which one of the gamma-hydrogens is substituted by a carboxy group.
gamma-carboxy-L-glutamic acid zwitterion
An amino acid zwitterion obtained from gamma-carboxy-L-glutamic acid by transfer of a proton from the alpha-carboxy group to the amino group.